G A Mueller1, T A Randall2, J Glesner3, L C Pedersen1, L Perera1, L L Edwards1, E F DeRose1, M D Chapman3, R E London1, A Pomés3. 1. Genome Integrity and Structural Biology Laboratory, Research Triangle Park, NC, USA. 2. Integrative Bioinformatics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA. 3. INDOOR Biotechnologies, Inc., Charlottesville, VA, USA.
Abstract
BACKGROUND: Der p 23 was recently identified in a European population as a major allergen and potentially a chitin binding protein. OBJECTIVE: This study sought to assess the importance of Der p 23 among other Dermatophagoides allergens in a North American population and to determine the structure for functional characterization. METHODS: IgE binding to Der p 23, Der p 1, Der p 2, Der p 5, Der p 7 and Der p 8 was measured by ELISA. RNA-seq data from D. pteronyssinus were compared as estimates of allergen expression levels. The structure was analysed by X-ray crystallography and NMR. RESULTS: Despite a high prevalence of Der p 23, (75% vs. 87% and 79% for Der p 1 and Der p 2, respectively), the anti-Der p 23 IgE levels were relatively low. The patient response to the 6 allergens tested was variable (n = 47), but on average anti-Der p 1 and anti-Der p 2 together accounted for 85% of the specific IgE. In terms of abundance, the RNA expression level of Der p 23 is the lowest of the major allergens, thirty fold less than Der p 1 and sevenfold less than Der p 2. The structure of Der p 23 is a small, globular protein stabilized by two disulphide bonds, which is structurally related to allergens such as Blo t 12 that contain carbohydrate binding domains that bind chitin. Functional assays failed to confirm chitin binding by Der p 23. CONCLUSIONS AND CLINICAL RELEVANCE: Der p 23 accounts for a small percentage of the IgE response to mite allergens, which is dominated by Der p 1 and Der p 2. The prevalence and amount of specific IgE to Der p 23 and Der p 2 are disproportionately high compared to the expression of other Dermatophagoides allergens. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Der p 23 was recently identified in a European population as a major allergen and potentially a chitin binding protein. OBJECTIVE: This study sought to assess the importance of Der p 23 among other Dermatophagoides allergens in a North American population and to determine the structure for functional characterization. METHODS:IgE binding to Der p 23, Der p 1, Der p 2, Der p 5, Der p 7 and Der p 8 was measured by ELISA. RNA-seq data from D. pteronyssinus were compared as estimates of allergen expression levels. The structure was analysed by X-ray crystallography and NMR. RESULTS: Despite a high prevalence of Der p 23, (75% vs. 87% and 79% for Der p 1 and Der p 2, respectively), the anti-Der p 23IgE levels were relatively low. The patient response to the 6 allergens tested was variable (n = 47), but on average anti-Der p 1 and anti-Der p 2 together accounted for 85% of the specific IgE. In terms of abundance, the RNA expression level of Der p 23 is the lowest of the major allergens, thirty fold less than Der p 1 and sevenfold less than Der p 2. The structure of Der p 23 is a small, globular protein stabilized by two disulphide bonds, which is structurally related to allergens such as Blo t 12 that contain carbohydrate binding domains that bind chitin. Functional assays failed to confirm chitin binding by Der p 23. CONCLUSIONS AND CLINICAL RELEVANCE: Der p 23 accounts for a small percentage of the IgE response to mite allergens, which is dominated by Der p 1 and Der p 2. The prevalence and amount of specific IgE to Der p 23 and Der p 2 are disproportionately high compared to the expression of other Dermatophagoides allergens. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
Der p 23; RNA-seq; allergen; house dust mite
Authors: Belinda J Hales; Andrew C Martin; Leigh J Pearce; Ingrid A Laing; Catherine M Hayden; Jack Goldblatt; Peter N Le Souëf; Wayne R Thomas Journal: J Allergy Clin Immunol Date: 2006-05-19 Impact factor: 10.793
Authors: D C Benjamin; J A Berzofsky; I J East; F R Gurd; C Hannum; S J Leach; E Margoliash; J G Michael; A Miller; E M Prager Journal: Annu Rev Immunol Date: 1984 Impact factor: 28.527
Authors: A P F Trombone; K R C Tobias; V P L Ferriani; J Schuurman; R C Aalberse; A M Smith; M D Chapman; L K Arruda Journal: Clin Exp Allergy Date: 2002-09 Impact factor: 5.018
Authors: Tiffany A Reese; Hong-Erh Liang; Andrew M Tager; Andrew D Luster; Nico Van Rooijen; David Voehringer; Richard M Locksley Journal: Nature Date: 2007-04-22 Impact factor: 49.962
Authors: Jill Glesner; A Brenda Kapingidza; Magdalena Godzwon; Lesa R Offermann; Geoffrey A Mueller; Eugene F DeRose; Paul Wright; Crystal M Richardson; Judith A Woodfolk; Lisa D Vailes; Sabina Wünschmann; Robert E London; Martin D Chapman; Mats Ohlin; Maksymilian Chruszcz; Anna Pomés Journal: J Immunol Date: 2019-09-25 Impact factor: 5.422
Authors: Anna Pomés; Jill Glesner; Agustin Calatroni; Cindy M Visness; Robert A Wood; George T O'Connor; Meyer Kattan; Leonard B Bacharier; Lisa M Wheatley; James E Gern; William W Busse Journal: J Allergy Clin Immunol Date: 2019-06-13 Impact factor: 10.793
Authors: Jill Glesner; Lisa D Vailes; Caleb Schlachter; Nicholas Mank; Wladek Minor; Tomasz Osinski; Maksymilian Chruszcz; Martin D Chapman; Anna Pomés Journal: J Immunol Date: 2016-12-30 Impact factor: 5.422
Authors: Carla Oseroff; Lars H Christensen; Luise Westernberg; John Pham; Jerome Lane; Sinu Paul; Jason Greenbaum; Thomas Stranzl; Gitte Lund; Ilka Hoof; Jens Holm; Peter A Würtzen; Kåre H Meno; April Frazier; Veronique Schulten; Peter S Andersen; Bjoern Peters; Alessandro Sette Journal: Clin Exp Allergy Date: 2016-11-07 Impact factor: 5.018